184 related articles for article (PubMed ID: 36332437)
1. The impact of the SARS-COV-2 pandemic on the quality of breast cancer care in EUSOMA-certified breast centres.
van Dam P; Tomatis M; Ponti A; Marotti L; Aristei C; Biganzoli L; Cardoso MJ; Cheung KL; Curigliano G; De Vries J; Santini D; Sardanelli F; Rubio IT;
Eur J Cancer; 2022 Dec; 177():72-79. PubMed ID: 36332437
[TBL] [Abstract][Full Text] [Related]
2. Changes in breast cancer management during the Corona Virus Disease 19 pandemic: An international survey of the European Breast Cancer Research Association of Surgical Trialists (EUBREAST).
Gasparri ML; Gentilini OD; Lueftner D; Kuehn T; Kaidar-Person O; Poortmans P
Breast; 2020 Aug; 52():110-115. PubMed ID: 32502796
[TBL] [Abstract][Full Text] [Related]
3. Time trends (2006-2015) of quality indicators in EUSOMA-certified breast centres.
van Dam PA; Tomatis M; Marotti L; Heil J; Mansel RE; Rosselli Del Turco M; van Dam PJ; Casella D; Bassani LG; Danei M; Denk A; Egle D; Emons G; Friedrichs K; Harbeck N; Kiechle M; Kimmig R; Koehler U; Kuemmel S; Maass N; Mayr C; Prové A; Rageth C; Regolo L; Lorenz-Salehi F; Sarlos D; Singer C; Sohn C; Staelens G; Tinterri C; Audisio R; Ponti A;
Eur J Cancer; 2017 Nov; 85():15-22. PubMed ID: 28881247
[TBL] [Abstract][Full Text] [Related]
4. Trends and variation in treatment of early breast cancer in European certified breast centres: an EUSOMA-based analysis.
van Walle L; Verhoeven D; Marotti L; Ponti A; Tomatis M; Rubio IT;
Eur J Cancer; 2023 Oct; 192():113244. PubMed ID: 37633095
[TBL] [Abstract][Full Text] [Related]
5. Management of early breast cancer during the COVID-19 pandemic in Brazil.
Cavalcante FP; Novita GG; Millen EC; Zerwes FP; de Oliveira VM; Sousa ALL; Freitas Junior R
Breast Cancer Res Treat; 2020 Nov; 184(2):637-647. PubMed ID: 32803637
[TBL] [Abstract][Full Text] [Related]
6. The process of EUSOMA certification improves the quality of breast cancer care: the experience of an Italian EUSOMA certificated Breast Unit (BU) according to the results of a cross-sectional study.
Gazzani D; Dai Prè A; Sandrini R; Governa M; Favaro A; Zogno A; Remo A; Greco F; Molinari E; Aguzzi G; Signorelli D; Caprara D; Costa L; Zanella C; Signorini M; Mercanti A; Giuliani J; Zambelli L; Majori S; Moretti F; Bonetti A
Recenti Prog Med; 2021 Jun; 112(6):458-464. PubMed ID: 34128938
[TBL] [Abstract][Full Text] [Related]
7. The effect of EUSOMA certification on quality of breast cancer care.
van Dam PA; Tomatis M; Marotti L; Heil J; Wilson R; Rosselli Del Turco M; Mayr C; Costa A; Danei M; Denk A; Emons G; Friedrichs K; Harbeck N; Kiechle M; Koheler U; Kuemmel S; Maass N; Marth C; Prové A; Kimmig R; Rageth C; Regolo L; Salehi L; Sarlos D; Singer C; Sohn C; Staelens G; Tinterri C; Ponti A; ;
Eur J Surg Oncol; 2015 Oct; 41(10):1423-9. PubMed ID: 26278019
[TBL] [Abstract][Full Text] [Related]
8. Global effect of the COVID-19 pandemic on paediatric cancer care: a cross-sectional study.
Graetz D; Agulnik A; Ranadive R; Vedaraju Y; Chen Y; Chantada G; Metzger ML; Mukkada S; Force LM; Friedrich P; Lam C; Sniderman E; Bhakta N; Hessissen L; Dalvi R; Devidas M; Pritchard-Jones K; Rodriguez-Galindo C; Moreira DC
Lancet Child Adolesc Health; 2021 May; 5(5):332-340. PubMed ID: 33675698
[TBL] [Abstract][Full Text] [Related]
9. EUSOMA quality indicators for non-metastatic breast cancer: An update.
Rubio IT; Marotti L; Biganzoli L; Aristei C; Athanasiou A; Campbell C; Cardoso F; Cardoso MJ; Coles CE; Eicher M; Harbeck N; Karakatsanis A; Offersen BV; Pijnappel R; Ponti A; Regitnig P; Santini D; Sardanelli F; Spanic T; Varga Z; Vrancken Peeters MJTFD; Wengström Y; Wyld L; Curigliano G
Eur J Cancer; 2024 Feb; 198():113500. PubMed ID: 38199146
[TBL] [Abstract][Full Text] [Related]
10. A cross-sectional survey study of the impact of COVID-19 pandemic on the training and quality of life of Italian medical residents in the Lombardy region.
Abati E; Nelva Stellio L; Manini A; Moroni F; Azzalini L; Vilca LM
Ann Med; 2022 Dec; 54(1):2326-2339. PubMed ID: 36001504
[TBL] [Abstract][Full Text] [Related]
11. Breast Cancer and SARS-Cov2: Lessons from a Pandemic.
Gosset M; Gal J; Schiappa R; Helwig C; Bonomo I; Delpech Y; Barranger E
Anticancer Res; 2023 May; 43(5):2235-2241. PubMed ID: 37097690
[TBL] [Abstract][Full Text] [Related]
12. Breast Cancer Management During COVID-19 Pandemic in Madrid: Surgical Strategy.
Brenes Sánchez JM; Picado AL; Olivares Crespo ME; García Sáenz JÁ; De La Plata Merlo RM; De La Muela MH
Clin Breast Cancer; 2021 Feb; 21(1):e128-e135. PubMed ID: 33223393
[TBL] [Abstract][Full Text] [Related]
13. Responses of paediatric emergency departments to the first wave of the COVID-19 pandemic in Europe: a cross-sectional survey study.
Rose K; Bressan S; Honeyford K; Bognar Z; Buonsenso D; Da Dalt L; De T; Farrugia R; Parri N; Oostenbrink R; Maconochie I; Moll HA; Roland D; Titomanlio L; Nijman R; ;
BMJ Paediatr Open; 2021 Dec; 5(1):. PubMed ID: 35413003
[TBL] [Abstract][Full Text] [Related]
14. Patient-reported treatment delays in breast cancer care during the COVID-19 pandemic.
Papautsky EL; Hamlish T
Breast Cancer Res Treat; 2020 Nov; 184(1):249-254. PubMed ID: 32772225
[TBL] [Abstract][Full Text] [Related]
15. Impact of the first lockdown for coronavirus 19 on breast cancer management in France: A multicentre survey.
Murris F; Huchon C; Zilberman S; Dabi Y; Phalippou J; Canlorbe G; Ballester M; Gauthier T; Avigdor S; Cirier J; Rua C; Legendre G; Darai E; Ouldamer L
J Gynecol Obstet Hum Reprod; 2021 Nov; 50(9):102166. PubMed ID: 34033966
[TBL] [Abstract][Full Text] [Related]
16. The Impact of the COVID-19 Pandemic on Surgical Management of Breast Cancer: Global Trends and Future Perspectives.
Rocco N; Montagna G; Di Micco R; Benson J; Criscitiello C; Chen L; Di Pace B; Esgueva Colmenarejo AJ; Harder Y; Karakatsanis A; Maglia A; Mele M; Nafissi N; Ferreira PS; Taher W; Tejerina A; Vinci A; Nava M; Catanuto G
Oncologist; 2021 Jan; 26(1):e66-e77. PubMed ID: 33044007
[TBL] [Abstract][Full Text] [Related]
17. COVID-19 after the first wave of the pandemic among employees from a German university hospital: prevalence and questionnaire data.
Sellmeier AC; Elsner A; Niedergassel T; Schmitz J; Rehberg S; Hornberg C; Vordemvenne T; Wähnert D
J Med Life; 2022 Sep; 15(9):1119-1128. PubMed ID: 36415516
[TBL] [Abstract][Full Text] [Related]
18. Using clinical cancer registry data for estimation of quality indicators: Results from the Norwegian breast cancer registry.
Hartmann-Johnsen OJ; Kåresen R; Schlichting E; Naume B; Nygård JF
Int J Med Inform; 2019 May; 125():102-109. PubMed ID: 30914174
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant endocrine therapy use in early stage breast cancer during the covid-19 pandemic.
Park KU; Gregory M; Bazan J; Lustberg M; Rosenberg S; Blinder V; Sharma P; Pusztai L; Shen C; Partridge A; Thompson A
Breast Cancer Res Treat; 2021 Jul; 188(1):249-258. PubMed ID: 33651271
[TBL] [Abstract][Full Text] [Related]
20. The impact of the COVID-19 pandemic on perioperative chemotherapy for breast cancer.
Baba K; Kawamoto M; Mamishin K; Uematsu M; Kiyohara H; Hirota A; Takahashi N; Fukuda M; Kusuhara S; Nakajima H; Funasaka C; Nakao T; Kondoh C; Harano K; Matsubara N; Naito Y; Hosono A; Kawasaki T; Mukohara T
Cancer Med; 2023 Jun; 12(11):12095-12105. PubMed ID: 37012214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
